High-performance capillary electrophoresis-pure creatine monohydrate reduces blood lipids in men and women

Clinical Science

Volumn 91, Issue 1, 1996, Pages 113-118

  Earnest, Conrad P ^a,d   Almada, Anthony L ^b   Mitchell, Tedd L ^c  

^a TEXAS WOMAN'S UNIVERSITY   (United States)

^b Experimental and Applied Sciences   (United States)

^c Cooper Clinic ^*  (United States)

^d NONE   (United States)

Author keywords

Cholesterol; Lipid metabolism; Triacylglycerols

Indexed keywords

ANTILIPEMIC AGENT; CREATINE; GLUCOSE;

ARTICLE; CAPILLARY ELECTROPHORESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL;

EID: 0029951120     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0910113     Document Type: Article

References (29)

1. Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci 1992; 83: 367-74.
2. Greenhaff PL, Casey A, Short AH, Harris R, Soderlund K, Hultman E. Influence of oral creatine supplementation of muscle torque during repeated bouts of maximal voluntary lifting exercise in man. Clin Sci 1993; 84: 565-71.
3. Balsom PD, Ekblomb B, Soderlund K, Sjodin B, Hultman E. Creatine supplementation and dynamic high intensity intermittent exercise. Scand J Med Sci Sports 1993; 3: 143-9.
4. Earnest CP, Snell PG, Rodriguez R, Almada AL, Mitchell TL. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand 1995; 153: 207-9.
5. Greenhaff P, Bodin K, Soderlund K, Hultman E. Effects of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol 1994; 266: E725-30.
6. Consensus development conference: lowering blood cholesterol to prevent heart disease. JAMA 1986; 253: 2080-6.
7. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196-204.
8. Schwartz J, Freeman R, Frishman W. Clinical pharmacology of estrogens; cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women. J Clin Pharmacol 1995; 35: 314-29.
9. The Writing Group for the PEPI Trial: effects of estrogen or estrogen/progestin therapy regimens on heart disease risk factors in postmenopausal women (the Postmenopausal Estrogen/Progestin Intervention (PEPI) trial). JAMA 1995; 273: 199-208.
10. Brees AJ, Cordain L, Harris M, Smith MJ, Almada AL Creatine ingestion does not influence leg extension power in meat eating and vegetarian females [Abstract]. FASEB J. 1994; 8: 1775.
11. Walker JB. Creatine: biosynthesis, regulation and function. In: Meister A, ed. Advances in enzymology and related areas of molecular biology. New York, NY: Interscience Publication. 1979; 50: 177-242.
12. Nash SR, Giros B, Kingmore SF, et al. Cloning, pharmacological characterization, and genome localization of the human creatine transporter. Receptors Channels 1994; 2: 165-74.
13. Forsberg AM, Nilsson E, Werneman J, Bergstrom J, Hultman E. Muscle composition in relation to age and sex. Clin Sci 1991; 81: 249-55.
14. Marin P, Oden B, Bjorntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 1995; 80: 239-43.
15. Crouse JR, Grundy SM. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia. Metabolism 1981; 30: 123-8.
16. Sane T, Knudsen P, Vorinen-Markkola H, Yki-Jarvinen H, Taskinen MR. Decreasing triglycerides by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia. Metabolism 1995; 44: 589-96.
17. Malloy MJ, Kane JP. Medical management of hyperlipidemic states. Adv Intern Med 1994; 39: 603-31.
18. 31P-n.m.r study of transgenic mice expressing creatine kinase (CKBB) in the liver. Biochem J 1994; 303: 531-8.
19. Agostini C, Bertoncello A, Colombo B. Effects of creatine administration on experimental liver fibrosis and on creatine and phosphocreatine content of rat muscle. Pharmacology 1981; 23: 145-8.
20. Rocic B, Zdenko, T, Misur I, Vucic M. Effect of creatine on glycation of albumin in vitro. Horm Metab Res 1995; 27: 511-12.
21. Steiner G, Vranic M. Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential. Int J Obesity 1982; 6: 117-24.
22. Sheu WH-H, Shieh SM, Fuh MM-T, et al. Insulin resistance, glucose tolerance, and hyperinsulinemia. Arterioscler Thromb 1933; 13: 367-70.
23. Jeppesen J, Hollenbcck CB, Zhou MY, et al. Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity and postprandial lipemia. Arterioscler Thromb Vasc Biol 1995; 15: 320-4.
24. Garg A, Helderman JH, Koffler M, Ayuso R, Rosenstock R, Raskin P. Relationship between lipoprotein levels and in vitro insulin action in young white men. Metabolism 1988; 37: 982-7.
25. Davidoff F. Guanidine derivatives in medicine. N Engl J Med 1973; 289: 141-6.
26. Hill RM. The effect of the administration of creatine on the blood sugar. J Biol Chem 1928; 78: iv.
27. Summary of the Second Report of the Nutritional Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269: 3015-23.
28. Patsch JR, Miesenbeck G, Hopferwieser T, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336-45.
29. Al-Habet SMH, Redda KK, Lee HJ. Uses and abuses of anabolic steroids by athletes. In: Redda KK, Walker CA, Barnett G, eds. Cocaine, marijuana, and designer drugs: chemistry, pharmacology, and behaviour. Boca Raton, FL, U.S.A.: CRC Press, 1989: 212-31.